The abstract is read at the publisher; the summary is JClub's.
H2AFY2 (macroH2A2) is identified as a critical regulator of CAR T-cell exhaustion in lymphoma patient-derived CAR T cells, consistently across multiple tumor models.
- Why it matters: Exhaustion limits durable antitumor activity of CAR T cells, and the field needs defined transcriptional and epigenetic regulators that can be targeted to sustain function.
- What they did: Transcriptomic profiling of CAR T cells from lymphoma patients highlighted H2AFY2; in mice, T cell-specific H2afy2 knockout increased inhibitory receptor expression via NF-κB and raised chromatin accessibility at the Rela locus, shown by single-cell RNA sequencing and ATAC-seq.
- The result: H2AFY2 overexpression in CD8+ T cells increased H3K27me3 at the Rela locus, suppressing p65-driven transcription, downregulating TOX, reducing exhaustion, and in CAR T-cell models sustaining lower inhibitory receptors and suppressing tumor recurrence.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.